Home > Healthcare > Drug Device Combination > Therapeutic Systems > Sclerotherapy Market

Sclerotherapy Market Size

Report ID: GMI12762
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Sclerotherapy Market Size

The global sclerotherapy market size was valued at USD 1.3 billion in 2024 and is projected to exhibit 6.1% CAGR from 2025 to 2034. The increasing prevalence of vascular disorders, rising demand for minimally invasive therapeutic procedures, regulatory approval of advanced sclerosants, and the growing adoption of sclerotherapy as a cost-effective alternative to surgery are driving revenue growth in the market.

To get key market trends

Download Free Sample

Sclerotherapy is a simple, minimally invasive procedure gaining popularity among patients seeking non-surgical treatments for vascular disorders. This procedure does not require general anesthesia, offers quicker recovery, reduces patient risks, and provides cost-effective benefits compared to traditional surgery. For example, the typical cost of varicose vein treatment through sclerotherapy ranges from USD 300 to 500, while surgical treatments, such as ambulatory phlebectomy, can cost between USD 2,000 and 4,000. As a result, many patients prefer the minimally invasive sclerotherapy over surgery, driving global market growth.

Sclerotherapy Market Report Attributes
Report Attribute	Details
Base Year:	2024
Sclerotherapy Market Size in 2024:	USD 1.3 Billion
Forecast Period:	2025 - 2034
Forecast Period 2025 - 2034 CAGR:	6.1%
2034 Value Projection:	USD 2.3 Billion
Historical Data for:	2021 - 2024
No. of Pages:	130
Tables, Charts & Figures:	120
Segments covered:	Agents, Therapy, Application, and Region
Growth Drivers:	Increasing prevalence of vascular disorders Rising demand for minimally invasive therapeutic procedures Regulatory approval of advanced sclerosants Increasing adoption as a cost-effective alternative to surgery
Pitfalls & Challenges:	Rise related to adverse reactions and complications Lack of reimbursement coverage

Learn more about the key segments shaping this market

Download Free Sample

Sclerotherapy is a minimally invasive procedure used to treat varicose and spider veins. During this procedure, a healthcare provider injects a chemical solution or foam (called a sclerosing agent) into the affected vein, causing the vein to collapse and stick together. Over time, the vein turns into scar tissue, which the body absorbs, making the vein disappear.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global sclerotherapy industry was valued at USD 1.3 billion in 2024 and is projected to grow at a 6.1% CAGR from 2025 to 2034, driven by the increasing prevalence of vascular disorders and rising demand for minimally invasive procedures.

The detergents segment accounted for 68.1% of the market share in 2024 due to their efficacy, safety profile, and versatility, with agents like polidocanol and sodium tetradecyl sulfate widely used for treating varicose and spider veins.

The U.S. sclerotherapy market generated approximately USD 483 million in 2024, supported by the high prevalence of vascular diseases, with 50% of individuals aged 50 and older affected by superficial venous disease.

Key players in the market include AngioDynamics, Bioniche Pharma Group, Boston Scientific Corporation, Changan Tianyu group, Chemische Fabrik Kreussler, Cook Medical, Endo-Flex (Meditek Systems), Erbe Elektromedizin, LGM Pharma, Medtronic, and MTW ENDOSKOPIE.